Trading of shares in QHR Corp. (TSXV:QHR), a Kelowna, B.C.-based medical records company that's becoming a subsidiary of Loblaw's Shoppers Drug Mart business, end Thursday.
The grocery and pharmacy giant acquired the small technology company for $170 million cash, or $3.10 per share.
That was 22 per cent above QHR's stock price prior to the announcement on Aug. 22. QHR shares closed Wednesday at $3.09 on the TSX Venture Exchange.
Loblaw (TSX:L) said QHR will be delisted after Thursday's trading day.
QHR currently supports 7,700 healthcare providers with a suite of secure medical records technology.
This content appears as provided to The Globe by the originating wire service. It has not been edited by Globe staff.